Clinical Overview: Lecanemab Offers Hope for Patients With Alzheimer Disease
Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody that targets amyloid plaques, which are thought to play a role in the development and progression of Alzheimer disease.